Avik Chakraborty

437 total citations
42 papers, 302 citations indexed

About

Avik Chakraborty is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Avik Chakraborty has authored 42 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Avik Chakraborty's work include Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Avik Chakraborty is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Avik Chakraborty collaborates with scholars based in India, United States and Netherlands. Avik Chakraborty's co-authors include Sharmila Banerjee, Vandana Soni, Anil D′Cruz, Shubhada Kane, Rita Mukhopadhyaya, Tanweer Haider, M. G. R. Rajan, Vikas Pandey, Joykrishna Dey and Rubel Chakravarty and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Langmuir.

In The Last Decade

Avik Chakraborty

35 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avik Chakraborty India 11 96 68 60 51 48 42 302
Karen Yang United States 9 192 2.0× 97 1.4× 38 0.6× 17 0.3× 36 0.8× 11 427
Marcel Costuleanu Romania 8 129 1.3× 89 1.3× 37 0.6× 19 0.4× 22 0.5× 41 421
Sukyung Ahn South Korea 8 210 2.2× 147 2.2× 15 0.3× 57 1.1× 39 0.8× 9 474
Haoran Ji China 5 47 0.5× 82 1.2× 9 0.1× 38 0.7× 22 0.5× 6 331
Wenyi Song China 7 183 1.9× 143 2.1× 11 0.2× 27 0.5× 17 0.4× 16 412
Patricia Gravel Switzerland 9 160 1.7× 96 1.4× 18 0.3× 19 0.4× 27 0.6× 13 362
Quanbing Chen China 7 140 1.5× 122 1.8× 14 0.2× 48 0.9× 6 0.1× 11 348
Silvia Sommaruga Italy 11 253 2.6× 119 1.8× 19 0.3× 54 1.1× 97 2.0× 13 413
Yufan Xiang China 9 129 1.3× 95 1.4× 7 0.1× 32 0.6× 29 0.6× 16 379
Weirong Kang Hong Kong 9 133 1.4× 68 1.0× 7 0.1× 93 1.8× 33 0.7× 13 354

Countries citing papers authored by Avik Chakraborty

Since Specialization
Citations

This map shows the geographic impact of Avik Chakraborty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avik Chakraborty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avik Chakraborty more than expected).

Fields of papers citing papers by Avik Chakraborty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avik Chakraborty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avik Chakraborty. The network helps show where Avik Chakraborty may publish in the future.

Co-authorship network of co-authors of Avik Chakraborty

This figure shows the co-authorship network connecting the top 25 collaborators of Avik Chakraborty. A scholar is included among the top collaborators of Avik Chakraborty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avik Chakraborty. Avik Chakraborty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakraborty, Avik, Chinagandham Rajesh, P. K. Chaudhuri, et al.. (2025). Convenient one-pot synthesis of 1-(4-(4-(2-[ 18 F]fluoroethoxy)phenyl)piperazin-1-yl)ethanone ([ 18 F]FEt-PPZ) for imaging tumors expressing sigma-1 receptors. RSC Advances. 15(29). 23943–23953.
2.
Chakraborty, Avik, et al.. (2025). Zwitterionic Carbon Nanodot-Desferrioxamine Conjugate for Improved Efficacy in Iron Overload Therapy. ACS Applied Nano Materials. 8(39). 19065–19075.
3.
Ghosh, Sanchita, Sumantra Bhattacharya, K.C. Barick, et al.. (2025). Bioinspired Synthesis of Intrinsically Radiolabeled Dy2O3 Nanoparticles as an In Vivo Generator of 166Dy/166Ho: A Smart Choice for Theranostics Engineering. ACS Applied Materials & Interfaces. 17(30). 42767–42780.
4.
Gupta, Santosh K., et al.. (2024). ZnAl2O4:Er3+ Upconversion Nanophosphor for SPECT Imaging and Luminescence Modulation via Defect Engineering. ACS Applied Bio Materials. 7(4). 2354–2366. 10 indexed citations
5.
Ghosh, Sanchita, Muhsin H. Younis, Avik Chakraborty, et al.. (2024). Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1558–1573. 4 indexed citations
8.
Ghosh, Sanchita, Apurav Guleria, Santosh K. Gupta, et al.. (2023). Intrinsically 69Ge-Labeled Gum Arabic Glycoprotein-Coated Gallium Oxide Nanoparticles: A New Nanoprobe for PET Imaging. Industrial & Engineering Chemistry Research. 62(47). 20269–20279. 4 indexed citations
9.
Srinivasu, K., Avik Chakraborty, Chandan Kumar, et al.. (2023). Chelator-Free Radiolabeling with Theoretical Insights and Preclinical Evaluation of Citrate-Functionalized Hydroxyapatite Nanospheres for Potential Use as Radionanomedicine. Industrial & Engineering Chemistry Research. 62(7). 3194–3205. 5 indexed citations
10.
Chakraborty, Avik, et al.. (2023). [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers. Nuclear Medicine and Biology. 118-119. 108331–108331. 2 indexed citations
11.
Mukherjee, Archana, et al.. (2022). 68 Ga-Labeled Trastuzumab Fragments for ImmunoPET Imaging of Human Epidermal Growth Factor Receptor 2 Expression in Solid Cancers. Cancer Biotherapy and Radiopharmaceuticals. 38(1). 38–50. 5 indexed citations
12.
Joshi, Rashmi, Bheeshma Pratap Singh, Avik Chakraborty, et al.. (2022). Mesoporous NaGdF4/Ho–Yb@m-SiO2 Upconversion Nanophosphors as a Potent Theranostic Probe. ACS Applied Nano Materials. 5(9). 12962–12971. 20 indexed citations
13.
Chakraborty, Avik, et al.. (2022). Synthesis and evaluation of [177Lu]Lu‐labeled porphyrin loaded PAMAM dendrimer: Impact on tumor uptake and pharmacokinetics. Drug Development Research. 83(8). 1777–1790. 1 indexed citations
14.
15.
Chakraborty, Avik, et al.. (2021). Therapeutic Multidose Preparation of a Ready-to-Use 177 Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy. Cancer Biotherapy and Radiopharmaceuticals. 36(8). 682–692. 4 indexed citations
16.
Chakraborty, Avik, et al.. (2021). Clinical efficacy of Sep-Pak® assisted one pot automated synthesis of pharmaceutical grade [18F]FLT using 5′-O-(benzoyl)-2,3′-anhydrothymidine precursor. Journal of Radioanalytical and Nuclear Chemistry. 327(1). 585–596. 1 indexed citations
17.
Pandey, Vikas, et al.. (2020). Technetium labeled doxorubicin loaded silk fibroin nanoparticles: Optimization, characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology. 56. 101539–101539. 12 indexed citations
18.
Chakraborty, Avik, et al.. (2020). Rheumatological Manifestations in HIV-Positive Patients: A Single-Center Study. Advances in Therapy. 37(10). 4336–4345. 4 indexed citations
19.
Chakraborty, Avik, et al.. (2019). Formulation and evaluation of letrozole-loaded spray dried liposomes with PEs for topical application. Journal of Liposome Research. 30(3). 274–284. 13 indexed citations
20.
Chakraborty, Avik, et al.. (2016). BACTERIOLOGICAL PROFILE AND ANTIBIOTIC SENSITIVITY PATTERN IN ACUTE EXACERBATION OF ADVANCED CASES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). SHILAP Revista de lepidopterología. 3(1). 20–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026